Pegcetacoplan (brand name: Empaveli) is a pegylated peptide that selectively inhibits complement component C3, decreasing both intravascular and extravascular hemolysis and controlling overactivation of the complement cascade. The directory classifies it as a commercial API with a peptide source/manufacturing origin. Other names for this substance include Nusinersen(ASO and Oligonucleotides). Its PubChem CID is 172915557.
Pegcetacoplan acetate
| CAS No | 2019171-69-6 |
|---|---|
| Molecular Formula | C62H100N16O23S2 |
| Molecular Weight | 1501.7 g/mol |
| Synonyms | acetic acid;(4S)-5-[[2-[[(2R)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[(2S)-2-[[(2S)-1-[[(2S)-1-[[(1S)-3-amino-1-carboxy-3-oxopropyl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-6-[[(2R,3R)-3-methyl-3,4-dihydro-2H-pyrrole-2-carbonyl]amino]-1-oxohexan-2-yl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-2-oxoethyl]amino]-5-oxo-4-[[(2S)-pyrrolidine-2-carbonyl]amino]pentanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pegcetacoplan (brand name: Empaveli) is a pegylated peptide that selectively inhibits complement component C3, decreasing both intravascular and extravascular hemolysis and controlling overactivation of the complement cascade.
The listed CAS number is 2019171-69-6.
The listed molecular formula is C62H100N16O23S2.
The listed molecular weight is 1501.7 g/mol.
The source lists Nusinersen(ASO and Oligonucleotides).
It is listed as a commercial API with a peptide origin.